Delivery Order 36F79721D0185-75D30123F16800

Award Date 6/7/23
Potential Completion Date 7/14/23
Potential Value $25K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mason, OH 45040, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order, awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh, is for $26,069.76 worth of atovaquone/proguanil tablets with no set-aside designation. The firm fixed price contract was awarded to Prasco, LLC and utilizes the Pharmaceuticals and Drugs schedule (FSS-61-IB) under the General Services Administration. Performance will occur in Mason, Ohio by August 30th, 2022. The atovaquone/proguanil tablets will support the...
Prasco, LLC was awarded a $24,647.04 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to provide 250mg/100mg doses of atovaquone/proguanil hydrochloride for the Centers for Disease Control and Prevention (CDC). The order is for Product #3 under the schedule and must be completed by August 15, 2023. Performance will take place in Mason, Ohio. No set-aside provisions were applied to this award to supply anti-malarial drugs in support of the CDC's global...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Prasco, LLC, a pharmaceutical company based in Mason, Ohio. The award is a firm-fixed-price delivery order valued at $24,491.52 for atovaquone/proguanil hydrochloride tablets, an antimalarial medication. The contract is part of a larger Indefinite Delivery Vehicle (IDV) contract that Prasco holds with the Department of Veterans Affairs under the Federal Supply Schedule for Pharmaceuticals and Drugs....
This is a $13,769.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 4,565,318,867 units of the prescription drug atovaquone-proguanil 250-100 mg, a malaria treatment. The contract has an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,470.75 firm fixed price delivery order is for Atovaquone-Proguanil 250-100 100s, a malaria medication. The contract has a completion date of May 16, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 IDC with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,009.57, is for the procurement of Atovaquone-Proguanil 250-100 UD 24S, a prescription medication used for the treatment and prevention of malaria. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
This federal contract award is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical tablets to the Medical Supply Chain, a defense agency. The $3,981.04 firm-fixed-price Delivery Order was awarded to Prasco, LLC, a pharmaceutical company based in Mason, Ohio. Prasco is an experienced federal contractor, holding several Indefinite Delivery Vehicle (IDV) contracts with the Department of Veterans Affairs (VA) for pharmaceutical and drug products, with a total ceiling value of over...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of Atovaquone-Proguanil 250-100 mg tablets, a prescription medication used to prevent and treat malaria. The contract has a firm fixed price of $3,083.70 and a period of performance through October 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at ninety-eight thousand five hundred eighty-one dollars and eighty-six cents ($98,581.86) to Amerisourcebergen Drug Corporation for the provision of two hundred fifty (250) tablets of atovaquone-proguanil and one hundred (100) tablets of the same medication. Performance will occur at the prime contractor's facility located in Conshohocken, Pennsylvania through August eighteenth, two thousand twenty-three (August 18,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $4,376.40 order is for the delivery of Atovaquone-Proguanil 250-100 mg tablets, a prescription antimalarial medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 awarded to...

This $24,647 delivery order was awarded to Prasco, LLC by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The order is placed against the Pharmaceuticals and Drugs Federal Supply Schedule contract vehicle and is for the delivery of 250mg Atovaquone and 100mg Proguanil Hydrochloride tablets. The completion date is July 14, 2023 and pricing is firm fixed. No set-aside designation was applied to this order for antimalarial medications, which will support the CDC's global disease prevention and health protection efforts through its Pittsburgh location.

Generated 1/2/24, 8:24 PM